SYDNEY, AUSTRALIA and SOUTH SAN FRANCISCO, CA—SpeeDx Pty. Ltd., a developer of innovative molecular diagnostic solutions, has signed an agreement with Thermo Fisher Scientific, the world leader in serving science, in support of SpeeDx’s plan to submit its ResistancePlus™ MG Test for clearance by the U.S. Food & Drug Administration (FDA). Under the terms of […]
Oxford Nanopore has launched a new analytical workflow for use with its real time nanopore sequencing devices. ‘ARMA’ allows characterisation of antimicrobial resistance genes in real time. The movie below shows real time analysis of pathogen DNA using two conjoined workflows: ‘What’s in my Pot’ (WIMP) is used for taxonomic classification of pathogens in a sample, […]
Singapore – JN Medsys, a life science company focused on developing cutting-edge genomic technologies, announced the appointment of Research Biolabs Pte Ltd as its distributor of the ClarityTM digital PCR system in both Singapore and Malaysia. This partnership aims to strengthen the presence of ClarityTM in Singapore while allowing it to expand into the Malaysia […]
BIRMINGHAM, Ala. — BioGX, a developer and manufacturer of molecular diagnostics CE-IVD tests has announced the establishment of European operations based in Amsterdam, Netherlands. BioGX EU operation is at the core of the company’s growth strategy into the European market with a goal to place sales, supply and support resources closer to its European customers. BioGX EU will […]
Oxford Nanopore has initiated its first legal proceedings in Europe against Pacific Biosciences* for infringement of EP1192453, which Oxford Nanopore has an exclusive right to commercialise under a license agreement with Harvard University. *refers to Pacific Biosciences Inc of California and Pacific Biosciences Ltd (UK).
Menlo Park, CA – Personalis, Inc., a precision medicine company focused on genomics solutions for immuno-oncology, cancer, and genetic disease, today announced the order of ten Illumina NovaSeq 6000 systems to continue to scale its operations in 2017. The first two instruments have now been delivered. Personalis is partnering with leading biopharmaceutical companies to accelerate cancer […]
Empirical Bioscience announced today that they have introduced a new Agarose Gel Extraction Kit that offers a simplified DNA purification process and robust results. Specifically designed to enhance efficiency, the kit arrives with the necessary components including, extraction buffer, activation buffer, washing buffer, elution buffer, spin columns, and collection tubes. Empirical Bioscience’s Agarose Gel Extraction […]
Cayman Chemical, in collaboration with BMG LABTECH GmbH, has developed a novel assay kit to measure mitochondrial function under a dynamic range of oxygen concentrations. The Mito Stress Test (ACU Format) is designed to measure oxygen consumption rate (OCR) and extracellular acidification (ECA) simultaneously and in real time under tightly controlled atmospheric conditions using open-flow respirometry. The assay […]
BERGISCH GLADBACH – MACS® GMP T Cell TransAct™ is a ready-to-use reagent for efficient in vitro activation and expansion of human T cells. Also available in research grade. Cell activation is a prerequisite for the successful genetic engineering of T cells. MACS GMP T Cell TransAct from Miltenyi Biotec – with its unique features – […]
Menlo Park, CA – Personalis, Inc., a precision medicine company focused on genomics solutions for immuno-oncology, cancer, and genetic disease, today announced the order of ten Illumina NovaSeq 6000 systems to continue to scale its operations in 2017. The first two instruments have now been delivered. Personalis is partnering with leading biopharmaceutical companies to accelerate cancer […]
Pay Invoice
Latest Blogs
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
